Literature DB >> 15254759

Effect of ghrelin on the apoptotic deletion rate of different types of cells cultured in vitro.

Anna S Belloni1, Carlo Macchi, Piera Rebuffat, Maria Teresa Conconi, Ludwik K Malendowicz, Pier Paolo Parnigotto, Gastone G Nussdorfer.   

Abstract

Evidence indicates that ghrelin, an endogenous ligand of the growth hormone secretagogue receptor, controls the growth of several human and rat cell types cultured in vitro. Hence, we have investigated, by using both TUNEL and ELISA assays, the effects of 10(-8) M ghrelin on the basal apoptotic deletion rate of rat osteoblasts and thymocytes, rat and human adrenocortical cells, human umbilical vein endothelial cells, and human aldosteronoma cells cultured in vitro, as well as of the human adrenocortical carcinoma-derived cell lines NCI-H295 and SW-13. Both assays consistently showed that ghrelin did not affect apoptotic rate of normal rat and human cells, but significantly enhanced apoptotic deletion in aldosteronoma, NCI-H295 and SW-13 cell cultures. Due to the central role of apoptosis in the control of tumor growth, these findings, if confirmed in other tumor cell types, could suggest an antitumoral action of ghrelin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254759

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  6 in total

Review 1.  Hormonal control of T-cell development in health and disease.

Authors:  Wilson Savino; Daniella Arêas Mendes-da-Cruz; Ailin Lepletier; Mireille Dardenne
Journal:  Nat Rev Endocrinol       Date:  2015-10-06       Impact factor: 43.330

2.  Ghrelin and cortistatin in lung cancer: expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line.

Authors:  P Cassoni; E Allia; T Marrocco; C Ghè; E Ghigo; G Muccioli; M Papotti
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

3.  Ghrelin is an Osteoblast Mitogen and Increases Osteoclastic Bone Resorption In Vitro.

Authors:  Jessica L Costa; Dorit Naot; Jian-Ming Lin; Maureen Watson; Karen E Callon; Ian R Reid; Andrew B Grey; Jillian Cornish
Journal:  Int J Pept       Date:  2011-09-08

4.  Ghrelin in central neurons.

Authors:  F Ferrini; C Salio; L Lossi; A Merighi
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

5.  Chronic central administration of Ghrelin increases bone mass through a mechanism independent of appetite regulation.

Authors:  Hyung Jin Choi; Kyoung Ho Ki; Jae-Yeon Yang; Bo Young Jang; Jung Ah Song; Wook-Young Baek; Jung Hee Kim; Jee Hyun An; Sang Wan Kim; Seong Yeon Kim; Jung-Eun Kim; Chan Soo Shin
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

6.  Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial.

Authors:  Keisuke Miki; Ryoji Maekura; Noritoshi Nagaya; Masamitsu Nakazato; Hiroshi Kimura; Shinsuke Murakami; Shunsuke Ohnishi; Toru Hiraga; Mari Miki; Seigo Kitada; Kenji Yoshimura; Yoshitaka Tateishi; Yasuji Arimura; Nobuhiro Matsumoto; Masanori Yoshikawa; Kenichi Yamahara; Kenji Kangawa
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.